title: Nocardia and Aspergillus Coinfection in a Patient with Ulcerative Colitis during Golimumab Therapy.
authors.affiliation: Gastroenterology Department, Clínica Universidad de Navarra, Pamplona, Spain mtalonso@unav.es.
authors.forename: Maite
authors.initials: M
authors.lastname: Alonso-Sierra
authors.affiliation: Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
authors.forename: Marta
authors.initials: M
authors.lastname: Calvo
authors.affiliation: Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
authors.forename: Yago
authors.initials: Y
authors.lastname: González-Lama
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D060085:Coinfection / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009617:Nocardia Infections / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis* / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; C529000:golimumab